(Q49210867)

19 February 2018

title

Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancer. (English)

1 reference

19 February 2018

author

William David Foulkes

10

1 reference

19 February 2018

author name string

Chappuis PO

1

1 reference

19 February 2018

Hamel N

2

1 reference

19 February 2018

Paradis AJ

3

1 reference

19 February 2018

Deschênes J

4

1 reference

19 February 2018

Robidoux A

5

1 reference

19 February 2018

Potvin C

6

1 reference

19 February 2018

Cantin J

7

1 reference

19 February 2018

Tonin P

8

1 reference

19 February 2018

Ghadirian P

9

1 reference

19 February 2018

publication date

1 June 2001

1 reference

19 February 2018

published in

Clinical Genetics

1 reference

19 February 2018

volume

59

1 reference

19 February 2018

page(s)

418-423

1 reference

19 February 2018

issue

6

1 reference

19 February 2018

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

THE GENETICS OF BREAST CANCER SUSCEPTIBILITY

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Prevalence of Mutations in the BRCA1 Gene Among Chinese Patients With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

Frequency of breast cancer attributable to BRCA1 in a population-based series of American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

Novel indications for BRCA1 screening using individual clinical and morphological features

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2001.590606.X

7 January 2021

10.1034/J.1399-0004.2001.590606.X

Identifiers

DOI

1 reference

19 February 2018

PubMed ID

11453973

1 reference

19 February 2018